These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23706899)

  • 1. Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder.
    Hopkins SC; Reasner DS; Koblan KS
    Psychiatry Res; 2013 Aug; 208(3):285-7. PubMed ID: 23706899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
    Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
    Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the COMT val158met variant with antidepressant treatment response in major depression.
    Baune BT; Hohoff C; Berger K; Neumann A; Mortensen S; Roehrs T; Deckert J; Arolt V; Domschke K
    Neuropsychopharmacology; 2008 Mar; 33(4):924-32. PubMed ID: 17522626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.
    Narasimhan S; Aquino TD; Multani PK; Rickels K; Lohoff FW
    Psychiatry Res; 2012 Jun; 198(1):112-5. PubMed ID: 22417933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
    Szegedi A; Rujescu D; Tadic A; Müller MJ; Kohnen R; Stassen HH; Dahmen N
    Pharmacogenomics J; 2005; 5(1):49-53. PubMed ID: 15520843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
    Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
    Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
    Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome.
    Fernández-de-Las-Peñas C; Ambite-Quesada S; Gil-Crujera A; Cigarán-Méndez M; Peñacoba-Puente C
    J Pain; 2012 Nov; 13(11):1068-74. PubMed ID: 23025981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression.
    Chiesa A; Lia L; Alberti S; Lee SJ; Han C; Patkar AA; Pae CU; Serretti A
    Int J Psychiatry Clin Pract; 2014 Jun; 18(2):97-102. PubMed ID: 24555772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
    Lee HY; Kim YK
    Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
    Corvol JC; Bonnet C; Charbonnier-Beaupel F; Bonnet AM; Fiévet MH; Bellanger A; Roze E; Meliksetyan G; Ben Djebara M; Hartmann A; Lacomblez L; Vrignaud C; Zahr N; Agid Y; Costentin J; Hulot JS; Vidailhet M
    Ann Neurol; 2011 Jan; 69(1):111-8. PubMed ID: 21280081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis.
    Watanabe K; Kakeda S; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umene-Nakano W; Watanabe R; Nakamura J; Korogi Y
    Psychiatry Res; 2015 Sep; 233(3):481-7. PubMed ID: 26253436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
    Arias B; Serretti A; Lorenzi C; Gastó C; Catalán R; Fañanás L
    J Affect Disord; 2006 Feb; 90(2-3):251-6. PubMed ID: 16356553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
    Rakvåg TT; Klepstad P; Baar C; Kvam TM; Dale O; Kaasa S; Krokan HE; Skorpen F
    Pain; 2005 Jul; 116(1-2):73-8. PubMed ID: 15927391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching.
    Colzato LS; Waszak F; Nieuwenhuis S; Posthuma D; Hommel B
    Neuropsychologia; 2010 Jul; 48(9):2764-8. PubMed ID: 20434465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder.
    Illi A; Setälä-Soikkeli E; Kampman O; Viikki M; Nuolivirta T; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
    Psychiatry Res; 2010 Mar; 176(1):85-7. PubMed ID: 20071037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.